FR2899768A1 - Food supplement, useful as antioxidant, to improve the organ response or prevent the oxidative stress and to reduce aging, comprises gamma-tocopherol, flavonoids, carnosic acid and carnosol - Google Patents
Food supplement, useful as antioxidant, to improve the organ response or prevent the oxidative stress and to reduce aging, comprises gamma-tocopherol, flavonoids, carnosic acid and carnosol Download PDFInfo
- Publication number
- FR2899768A1 FR2899768A1 FR0603423A FR0603423A FR2899768A1 FR 2899768 A1 FR2899768 A1 FR 2899768A1 FR 0603423 A FR0603423 A FR 0603423A FR 0603423 A FR0603423 A FR 0603423A FR 2899768 A1 FR2899768 A1 FR 2899768A1
- Authority
- FR
- France
- Prior art keywords
- extract
- dietary supplement
- tocopherol
- supplement according
- carnosol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 43
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 title claims abstract description 31
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 235000010382 gamma-tocopherol Nutrition 0.000 title claims abstract description 18
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 title claims abstract description 18
- 239000002478 γ-tocopherol Substances 0.000 title claims abstract description 18
- 229930003935 flavonoid Natural products 0.000 title claims abstract description 11
- 235000017173 flavonoids Nutrition 0.000 title claims abstract description 11
- 150000002215 flavonoids Chemical class 0.000 title claims abstract description 11
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 title claims abstract description 9
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 235000004654 carnosol Nutrition 0.000 title claims abstract description 9
- 230000003078 antioxidant effect Effects 0.000 title description 19
- 239000003963 antioxidant agent Substances 0.000 title description 16
- 235000006708 antioxidants Nutrition 0.000 title description 16
- 230000036542 oxidative stress Effects 0.000 title description 12
- 230000032683 aging Effects 0.000 title description 3
- 230000004044 response Effects 0.000 title description 3
- 210000000056 organ Anatomy 0.000 title 1
- 239000000284 extract Substances 0.000 claims description 30
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 26
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 20
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 12
- 229910052711 selenium Inorganic materials 0.000 claims description 12
- 239000011669 selenium Substances 0.000 claims description 12
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 10
- 235000014837 Malpighia glabra Nutrition 0.000 claims description 10
- 240000003394 Malpighia glabra Species 0.000 claims description 10
- 244000078534 Vaccinium myrtillus Species 0.000 claims description 10
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 10
- 235000010323 ascorbic acid Nutrition 0.000 claims description 10
- 239000011668 ascorbic acid Substances 0.000 claims description 10
- 229960005070 ascorbic acid Drugs 0.000 claims description 10
- 235000019359 magnesium stearate Nutrition 0.000 claims description 10
- 235000011649 selenium Nutrition 0.000 claims description 10
- 239000000600 sorbitol Substances 0.000 claims description 10
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 8
- 229940094952 green tea extract Drugs 0.000 claims description 8
- 235000020688 green tea extract Nutrition 0.000 claims description 8
- 235000010356 sorbitol Nutrition 0.000 claims description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 7
- 235000009529 zinc sulphate Nutrition 0.000 claims description 7
- 239000011686 zinc sulphate Substances 0.000 claims description 7
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 6
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 6
- 240000006365 Vitis vinifera Species 0.000 claims description 6
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 6
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 6
- 235000005487 catechin Nutrition 0.000 claims description 6
- 150000001765 catechin Chemical class 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 5
- 229920001991 Proanthocyanidin Polymers 0.000 claims description 4
- 229940038487 grape extract Drugs 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 229940092258 rosemary extract Drugs 0.000 claims description 3
- 235000020748 rosemary extract Nutrition 0.000 claims description 3
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 3
- 229940055416 blueberry extract Drugs 0.000 claims description 2
- 235000019216 blueberry extract Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000001777 nootropic effect Effects 0.000 abstract 1
- 229940125725 tranquilizer Drugs 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 description 11
- 239000011709 vitamin E Substances 0.000 description 11
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 235000019154 vitamin C Nutrition 0.000 description 9
- 239000011718 vitamin C Substances 0.000 description 9
- 235000005911 diet Nutrition 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 5
- 235000012055 fruits and vegetables Nutrition 0.000 description 5
- 230000006851 antioxidant defense Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 235000016804 zinc Nutrition 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 229940087168 alpha tocopherol Drugs 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 235000004835 α-tocopherol Nutrition 0.000 description 3
- 239000002076 α-tocopherol Substances 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000012261 overproduction Methods 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- HDZNCKLMVPZWDN-UHFFFAOYSA-N 1-benzyl-n-[(2-fluorophenyl)methyl]-3,5-dimethylpyrazole-4-carboxamide Chemical compound CC1=C(C(=O)NCC=2C(=CC=CC=2)F)C(C)=NN1CC1=CC=CC=C1 HDZNCKLMVPZWDN-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
La présente invention concerne un complément alimentaire améliorant laThe present invention relates to a dietary supplement improving the
réponse de l'organisme en réponse ou en prévention du stress oxydatif. D'une manière générale, un complément alimentaire (ou complément nutrition- nel) est un ensemble comestible destiné à compléter l'alimentation quotidienne d'un organisme humain en lui fournissant des nutriments ayant pour fonction de le renforcer ou d'atténuer, voire éliminer, un symptôme affectant celui-ci. response of the body in response to or prevention of oxidative stress. In general, a dietary supplement (or nutritional supplement) is an edible set intended to supplement the daily diet of a human organism by providing nutrients whose function is to strengthen it or to reduce or eliminate , a symptom affecting this one.
ARRIERE PLAN DE L'INVENTION Le stress oxydatif est aujourd'hui reconnu par la communauté scientifique comme un état physiologique perturbé qui est directement relié à plus de 200 maladies, qui vont des troubles cardiovasculaires, à la dégénéres- cence maculaire liée à l'âge en passant par les maladies de Parkinson et d'Alzheimer. Le stress oxydatif se définit par la surproduction de radicaux libres (ou espèces oxygénées réactives) par rapport aux défenses antioxydantes de l'organisme. Le 2.0 stress oxydatif est également considéré par la communauté scientifique comme un des principaux mécanismes responsables du vieillissement. L'ensembie de la population est concernée par le stress oxydatif car les facteurs favorisant la surproduc- 25 tion de radicaux libres sont nombreux et courants : expo- sition au soleil, stress psychologique, tabagisme, pollu- tion, surcharge pondérale, alimentation pro-oxydante (surconsommation de sucres simples, aliments riches en mauvais cholestérol LDL)... 30 L'alimentation est une source importante d'antioxydants pour permettre de lutter contre le stress oxydatif. Les fruits et légumes sont les aliments les plus antioxydants, c'est pourquoi il est généralement conseillé de manger cinq fruits et légumes par jour. Tou- 35 tefois, les études nutritionnelles montrent que la plu- 2 part des personnes n'atteignent pas ce seuil recommandé : d'après l'enquête INCA 1998 et 1999 et le Baromètre Santé Nutrition 2002, 60 % des français mangent moins de une portion et demi de fruits et moins de deux portions de légumes par jour. Cette sous-consommation de fruits et légumes est donc un handicap en terme de prévention de maladies. En effet l'étude SU.VI. MAX a démontré que la consommation d'antioxydants à des doses nutritionnelles permettait de réduire chez les hommes la mortalité de 37% et le risque de cancer de 31%. Or, il suffit d'une perturbation dje notre mode de vie (événement stressant, émotion forte, régime) pour que notre organisme n'arrive plus à produire suffisamment de défenses antioxydantes pour lutter contre l'augmentation de la production de radicaux libres. Ajoutée à une consommation insuffisante de fruits et légumes, une telle perturbation ou tout simplement l'adoption d'un mode de vie peu sain (habiter dans une grande ville polluée, être stressé(e) par son travail, avoir une alimentation désé- quilibrée) peut donc très facilement occasionner l'apparition d'un stress oxydatif et donc accélérer le processus de vieillissement. Certains compléments alimentaires antioxydants ont été lancés ces dernières années mais la mesure de leur pouvoir antioxydant révèle qu'ils apportent finale-ment une faible dose d'antioxydants par rapport aux fruits et aux légumes. De plus les apports en antioxydants doivent être variés et ne pas se limiter à deux, trois ou quatre molécules antioxydantes (comme c'est le cas dans de nombreux produits actuellement sur le marché) afin de ne pas perturber les équilibres redox internes et éviter ainsi le développement du stress oxydatif. OBJET DE L'INVENTION Il serait donc intéressant de disposer d'un nou- veau moyen facile à utiliser favorisant le maintien ou le 3 retour à un équilibre interne entre la production de radicaux libres et le niveau de défenses antioxydantes afin d'éviter de développer un stress oxydatif. DESCRIPTION DETAILLEE DE L'INVENTION A cet effet, on prévoit selon l'invention, un complément alimentaire comprenant du gamma-tocophérol, des flavonoïdes, de l'acide carnosique et du carnosol. Le gamma-tocophérol est une des formes existantes de la vitamine E dans l'alimentation, tout comme l'alpha- I0 tocophérol. La vitamine E est un puissant antioxydant. Toutefois c'est le rapport alpha-tocophérol sur gamma-tocophérol qui pilote l'action antioxydante. Or il s'avère que la quasi-totalité des compléments alimentaires apportant de la vitamine E le font sous forme 15 d'alpha-tocophérol, ce qui crée un déséquilibre dans l'organisme. Les recherches scientifiques ont montré qu'augmenter la proportion de gamma-tocophérol par rapport à l'alpha-tocophérol permettait de mieux prévenir les maladies cardiovasculaires. 20 L'intérêt des flavonoïdes est double car d'une part les flavonoïdes neutralisent directement les radicaux libres et d'autre part ils agissent en synergie avec les vitamines C et E dans la neutralisation des radicaux libres. En effet les vitamines C et E donnent un électron 25 aux radicaux libres afin de les stabiliser. Mais ensuite ces vitamines C et E se retrouvent sous forme oxydée et ne peuvent plus lutter contre les radicaux libres. Les flavonoïdes permettent de régénérer sous forme réduite les vitamines C et E afin de continuer à lutter contre 30 les radicaux libres. Selon un mode de réalisation particulier, le complément alimentaire comprend : - de l'acide carnosique et du carnosol, - des oligo-proanthocyanidines, 35 - du gamma-tocophérol, 4 - des catéchines et biflavanes. Les oligo-proanthocyanidines sont des flavonoïdes dont l'activité antioxydante est 50 fois supérieure à celle des vitamines C et E. L'acide carnosique et le car- nosol sont de puissants antioxydants qui viennent renforcer l'action des oligo-proanthocyanidines dans la lutte contre les radicaux libres et la régénération des formes actives des vitamines C et E. De préférence, le complément alimentaire com- prend : - un extrait sec de romarin contenant de l'acide carnosique et du carnosol, - un extrait sec de raisin contenant des oligoproanthocyanidines, - un extrait de soja contenant du gamma-tocophérol, - un extrait sec de myrtille contenant des catéchines et biflavanes. L'extrait de myrtille apporte également de la 2.0 vitamine C. La vitamine C est hydrophile donc elle exerce son activité antioxydante principalement en milieu aqueux. La vitamine E est lipophile et exerce donc son action antioxydante en milieu lipidique. Les oligoproanthocyanidines complètent donc de manière intéres- 25 sante dans un complément alimentaire les vitamines C et E car leur action antioxydante s'exerce à la fois en milieu aqueux et milieu lipidique. L'intérêt des extraits de raisin, myrtille et ro-marin réside également dans le fait qu'en tant que subs- 30 tance naturelle non purifiée ils apportent de nombreux composés antioxydants qui ne se limitent pas à ceux cités précédemment. C'est cet apport de nombreux antioxydants qui permet d'agir sur de multiples chaînes d'oxydoréduction de l'organisme et ainsi d'induire un équilibre 35 entre production de radicaux libres et défenses antioxy- dantes de manière générale dans tout l'organisme. De préférence, le complément alimentaire comprend un extrait de thé vert, un extrait d'acérola, de l'acide ascorbique, du sélénium et du zinc. 5 Les extraits de thé vert et d'acérola, l'acide ascorbique, le sélénium et le zinc sont des composés antioxydants qui viennent renforcer l'action antioxydante du complément alimentaire. L'action antioxydante du complément alimentaire est mesurée grâce au test CRAC et garantit au minimum 2000 unités ORAC. Cette preuve de l'efficacité de ce complément alimentaire est importante car d'une part de nombreux autres compléments alimentaires antioxydants actuellement commercialisés ont en réalité un faible pou- voir antioxydant. D'autre part des nutritionnistes américains conseillent de consommer entre 3000 et 5000 unités ORAC par jour afin de limiter le vieillissement de l'organisme et de prévenir le stress oxydatif. Or l'alimentation des Français n'apporte que 1500 unités CRAC chaque jour. Donc le complément alimentaire ci-dessus est un moyen efficace de lutter contre le stress oxydatif puisque son action antioxydante en complément de l'alimentation est prouvée. D'autres caractéristiques et avantages de l'in- vention ressortiront à la lecture de la description qui suit d'un mode de réalisation particulier non limitatif de l'invention. Le complément alimentaire conforme à l'invention comprend un extrait sec de soja, de raisin, de myrtille et de romarin. L'extrait de soja est garanti non OGM et dosé entre 18 et 21 de gamma-tocophérol environ. L'extrait sec de raisin est du marc de raisin présenté sous forme de poudre obtenue par pulvérisation du marc séché et tamisage de la poudre obtenue. BACKGROUND OF THE INVENTION Oxidative stress is now recognized by the scientific community as a disrupted physiological condition that is directly related to more than 200 diseases, ranging from cardiovascular disorders, to age-related macular degeneration. going through Parkinson's and Alzheimer's diseases. Oxidative stress is defined by the overproduction of free radicals (or reactive oxygen species) in relation to the antioxidant defenses of the body. Oxidative stress is also considered by the scientific community as one of the main mechanisms responsible for aging. The whole population is affected by oxidative stress because the factors promoting the overproduction of free radicals are numerous and common: exposure to the sun, psychological stress, smoking, pollution, overweight, diet oxidative (overconsumption of simple sugars, foods rich in bad LDL cholesterol) ... Food is an important source of antioxidants to help fight against oxidative stress. Fruits and vegetables are the most antioxidant foods, so it is generally advisable to eat five fruits and vegetables a day. However, nutritional studies show that most people do not reach this recommended threshold: according to the CNIB 1998 and 1999 survey and the 2002 Health Nutrition Barometer, 60% of French people eat less than one person. serving and a half of fruit and less than two servings of vegetables a day. This under-consumption of fruits and vegetables is therefore a handicap in terms of disease prevention. Indeed the study SU.VI. MAX has shown that the consumption of antioxidants at nutritional levels reduces mortality in men by 37% and cancer risk by 31%. However, it suffices to disrupt our lifestyle (stressful event, strong emotion, diet) so that our body can no longer produce enough antioxidant defenses to fight against the increase in the production of free radicals. Added to an insufficient consumption of fruit and vegetables, such a disruption or simply the adoption of an unhealthy lifestyle (living in a large polluted city, being stressed by one's work, having an unbalanced diet ) can very easily cause the onset of oxidative stress and thus accelerate the aging process. Some antioxidant dietary supplements have been launched in recent years, but the measure of their antioxidant power reveals that they ultimately provide a low dose of antioxidants compared to fruits and vegetables. In addition, the antioxidant intake must be varied and not be limited to two, three or four antioxidant molecules (as is the case in many products currently on the market) so as not to disturb the internal redox equilibrium and thus avoid the development of oxidative stress. OBJECT OF THE INVENTION It would therefore be advantageous to have a new easy-to-use means for maintaining or returning to an internal balance between the production of free radicals and the level of antioxidant defenses in order to avoid developing oxidative stress. DETAILED DESCRIPTION OF THE INVENTION For this purpose, there is provided according to the invention, a dietary supplement comprising gamma-tocopherol, flavonoids, carnosic acid and carnosol. Gamma-tocopherol is one of the existing forms of vitamin E in the diet, as is alpha-I-tocopherol. Vitamin E is a powerful antioxidant. However, it is the alpha-tocopherol ratio on gamma-tocopherol that drives the antioxidant action. However, it turns out that almost all food supplements providing vitamin E do so in the form of alpha-tocopherol, which creates an imbalance in the body. Scientific research has shown that increasing the proportion of gamma-tocopherol relative to alpha-tocopherol can better prevent cardiovascular disease. The interest of flavonoids is twofold because on the one hand flavonoids directly neutralize free radicals and on the other hand they act synergistically with vitamins C and E in the neutralization of free radicals. Indeed vitamins C and E give an electron 25 to free radicals to stabilize them. But then these vitamins C and E are found in oxidized form and can no longer fight against free radicals. Flavonoids make it possible to regenerate in reduced form vitamins C and E in order to continue to fight against free radicals. According to a particular embodiment, the dietary supplement comprises: carnosic acid and carnosol, oligo-proanthocyanidines, gamma-tocopherol, catechins and biflavans. Oligo-proanthocyanidins are flavonoids with antioxidant activity 50 times higher than vitamins C and E. Carnosic acid and carsonol are powerful antioxidants that enhance the action of oligo-proanthocyanidins in the fight against against free radicals and the regeneration of the active forms of vitamins C and E. Preferably, the food supplement comprises: - a dry extract of rosemary containing carnosic acid and carnosol, - a dry extract of grapes containing oligoproanthocyanidins, - a soybean extract containing gamma-tocopherol, - a bilberry dry extract containing catechins and biflavans. The blueberry extract also brings 2.0 vitamin C. Vitamin C is hydrophilic so it exerts its antioxidant activity mainly in aqueous medium. Vitamin E is lipophilic and therefore exerts its antioxidant action in a lipidic medium. Oligoproanthocyanidins thus complement vitamin C and E in a dietary supplement because their antioxidant action is exercised both in an aqueous medium and in a lipidic medium. The interest of grape, blueberry and ro-marine extracts also lies in the fact that, as a natural unpurified substance, they provide numerous antioxidant compounds which are not limited to those mentioned above. It is this contribution of numerous antioxidants which makes it possible to act on multiple oxidoreduction chains of the organism and thus to induce a balance between production of free radicals and antioxidant defenses generally throughout the body. . Preferably, the dietary supplement comprises green tea extract, acerola extract, ascorbic acid, selenium and zinc. 5 Extracts of green tea and acerola, ascorbic acid, selenium and zinc are antioxidant compounds that enhance the antioxidant action of the dietary supplement. The antioxidant action of the food supplement is measured using the CRAC test and guarantees at least 2000 ORAC units. This proof of the effectiveness of this dietary supplement is important because on the one hand many other antioxidant food supplements currently marketed have in fact a low antioxidant power. On the other hand American nutritionists advise to consume between 3000 and 5000 ORAC units per day in order to limit the aging of the body and to prevent oxidative stress. But the diet of the French brings only 1500 CRAC units each day. So the food supplement above is an effective way to fight against oxidative stress since its antioxidant action in addition to food is proven. Other characteristics and advantages of the invention will become apparent on reading the following description of a particular non-limiting embodiment of the invention. The food supplement according to the invention comprises a dry extract of soy, grape, blueberry and rosemary. The soy extract is guaranteed non-GMO and dosed between 18 and 21 gamma-tocopherol approximately. The dry grape extract is grape pomace presented in the form of a powder obtained by spraying the dried pomace and sieving the powder obtained.
L'extrait sec de myrtille contient 25% d'anthocyanidines et a été obtenu par une méthode d'extraction hydroalcoolique (alcool/eau dans un rapport 80 : 20) du fruit de la plante. The bilberry dry extract contains 25% anthocyanidins and was obtained by a hydroalcoholic extraction method (alcohol / water ratio 80:20) of the fruit of the plant.
L'extrait sec de romarin est obtenu à partir des feuilles de romarin avec de l'éthanol à 30%. Le complément alimentaire comprend en outre un extrait de thé vert, un extrait d'acérola, du sélénium sous forme de levure de sélénium, du zinc sous forme de sulfate de zinc, de l'acide ascorbique, du sorbitol et du stéarate de magnésium. Le complément alimentaire comprend, en poids, en-viron . - 23% d'extrait sec de romarin - 4 % d'extrait sec de raisin, - 3% de gamma-tocophérol, - 2% d'extrait sec de myrtille, - 12% d'extrait de thé vert, - 3% de sulfate de zinc, - 3% de levure de sélénium, - 2% d'extrait d'acérola, - 2% d'acide ascorbique, - 43% de sorbitol, - 2% de stéarate de magnésium. Plus précisément, le complément alimentaire se présente ici sous la forme d'un comprimé de 650 mg. La composition de ce comprimé est de : - 150 mg d'extrait sec de romarin mg d'extrait sec de raisin, - 18,35 mg de gamma-tocophérol - 15 mg d'extrait sec de myrtille - 80 mg d'extrait de thé vert - 21 mg de sulfate de zinc - 18,75 mg de levure de sélénium - 15 mg d'extrait d'acérola 20 25 30 35 7 - 12,85 mg d'acide ascorbique - 281,05 mg de sorbitol - 13 mg de stéarate de magnésium. Une posologie adaptée à une grande part des cas est de 2 comprimés par jour. Les différents constituants se présentent sous forme de poudres qui sont mélangées en tamisant dans l'ordre . - la moitié du sorbitol, - les autres composants à l'exception du stéarate de magnésium, - le reste du sorbitol, - le stéarate de magnésium. Bien entendu, l'invention n'est pas limitée au mode de réalisation décrit et on peut y apporter des va-riantes de réalisation sans sortir du cadre de l'invention tel que défini par les revendicationsä En particulier, la composition du complément alimentaire peut être différente de celle décrite et ne pas comporter par exemple d'extrait de thé vert, d'extrait d'acérola, du sélénium sous forme de levure de sélénium, du zinc sous forme de sulfate de zinc, de l'acide ascorbique, du sorbitol et du stéarate de magnésium... Ces composants peuvent être supprimés ou remplacer par des com- posants équivalents. Le gamma-tocophérol, les oligoproanthocyanidines, les catéchines et biflavanes et l'acide carnosique peuvent en outre être fournis par d'autres ingrédients que le soja, le marc de raisin, la myrtille et le romarin. Le complément alimentaire peut incorporer d'autres flavonoïdes que ceux décrits. Le complément alimentaire peut se présenter sous d'autres formes galéniques et par exemple sous forme de gélules, la composition du complémentaire pouvant alors incorporer un excipient. The dry extract of rosemary is obtained from rosemary leaves with 30% ethanol. The dietary supplement further comprises green tea extract, acerola extract, selenium in the form of selenium yeast, zinc in the form of zinc sulphate, ascorbic acid, sorbitol and magnesium stearate. The dietary supplement comprises, by weight, approximately. - 23% dry rosemary extract - 4% dry grape extract, - 3% gamma-tocopherol, - 2% bilberry dry extract, - 12% green tea extract, - 3% zinc sulphate, - 3% selenium yeast, - 2% acerola extract, - 2% ascorbic acid, - 43% sorbitol, - 2% magnesium stearate. More specifically, the dietary supplement is here in the form of a 650 mg tablet. The composition of this tablet is: - 150 mg dry extract of rosemary mg dry extract of grapes, - 18.35 mg of gamma-tocopherol - 15 mg of dry extract of blueberry - 80 mg of extract of green tea - 21 mg of zinc sulphate - 18.75 mg of selenium yeast - 15 mg of acerola extract 20 25 30 35 7 - 12.85 mg of ascorbic acid - 281.05 mg of sorbitol - 13 mg of magnesium stearate. A dosage adapted to a large part of the cases is 2 tablets per day. The various constituents are in the form of powders which are mixed by sieving in order. - half of the sorbitol, - the other ingredients with the exception of magnesium stearate, - the rest of the sorbitol, - the magnesium stearate. Of course, the invention is not limited to the embodiment described and it is possible to provide variations thereto without departing from the scope of the invention as defined by the claims In particular, the composition of the dietary supplement may be different from that described and not include, for example, green tea extract, acerola extract, selenium in the form of selenium yeast, zinc in the form of zinc sulphate, ascorbic acid, sorbitol and magnesium stearate ... These components can be removed or replaced with equivalent components. Gamma-tocopherol, oligoproanthocyanidines, catechins and biflavans and carnosic acid may additionally be provided by other ingredients than soybean, grape marc, bilberry and rosemary. The dietary supplement may incorporate other flavonoids than those described. The dietary supplement may be in other galenic forms and for example in the form of capsules, the composition of the supplement can then incorporate an excipient.
Ainsi, selon une autre formulation, le complément 1 0 8 alimentaire peut comprendre, en poids, environ : - 20% d'extrait sec de romarin, - 7 d'extrait sec de raisin, - 3% de gamma-tocophérol, - 7% d'extrait sec de myrtille, - 8% d'extrait de thé vert, - 3% de sulfate de zinc, - 3% de levure de sélénium, - 2% d'extrait d'acérola, - 1% d'acide ascorbique, -44% de sorbitol, - 2% de stéarate de magnésium. Thus, according to another formulation, the food supplement may comprise, by weight, approximately: - 20% of dry extract of rosemary, - 7 of dry grape extract, - 3% of gamma-tocopherol, - 7 % bilberry dry extract, - 8% green tea extract, - 3% zinc sulphate, - 3% selenium yeast, - 2% acerola extract, - 1% acid ascorbic acid, -44% sorbitol, - 2% magnesium stearate.
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603423A FR2899768B1 (en) | 2006-04-14 | 2006-04-14 | ANTIOXIDANT FOOD SUPPLEMENT COMPRISING OLIGOPROANTHOCYANIDES, GAMMA-TOCOPHEROL, CATECHINS AND BIFLAVANES, CARNOSIC ACID AND CARNOSOL |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603423A FR2899768B1 (en) | 2006-04-14 | 2006-04-14 | ANTIOXIDANT FOOD SUPPLEMENT COMPRISING OLIGOPROANTHOCYANIDES, GAMMA-TOCOPHEROL, CATECHINS AND BIFLAVANES, CARNOSIC ACID AND CARNOSOL |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2899768A1 true FR2899768A1 (en) | 2007-10-19 |
FR2899768B1 FR2899768B1 (en) | 2008-06-20 |
Family
ID=37497972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0603423A Expired - Fee Related FR2899768B1 (en) | 2006-04-14 | 2006-04-14 | ANTIOXIDANT FOOD SUPPLEMENT COMPRISING OLIGOPROANTHOCYANIDES, GAMMA-TOCOPHEROL, CATECHINS AND BIFLAVANES, CARNOSIC ACID AND CARNOSOL |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2899768B1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009052924A1 (en) * | 2007-10-22 | 2009-04-30 | Dsm Ip Assets B.V. | Process for producing carnosol from carnosic acid |
EP2062899A1 (en) * | 2007-11-21 | 2009-05-27 | DSMIP Assets B.V. | Process for producing carnosol from carnosic acid |
WO2009127073A1 (en) * | 2008-04-18 | 2009-10-22 | Gen Sod2 Foundation | Cosmetic preparation tailored to an individual and method for the production thereof |
WO2014083172A1 (en) * | 2012-11-29 | 2014-06-05 | Nestec S.A. | Increasing the bioavailability of flavan-3-ols by polyphenols |
WO2014083161A1 (en) * | 2012-11-29 | 2014-06-05 | Nestec S.A. | Increasing the bioavailability of flavan-3-ols with carbohydrates with a low glycemic index |
EP2753311A1 (en) * | 2011-09-09 | 2014-07-16 | Kemin Industries, Inc. | Antioxidant formulations |
WO2021245362A1 (en) * | 2020-06-05 | 2021-12-09 | Adisseo France S.A.S. | Vitamin a formulation |
WO2022018281A3 (en) * | 2020-07-24 | 2022-03-10 | Activ'inside | Composition comprising a mixture of extracts of vitis vinifera and vaccinium angustifolium and probiotics to improve cognitive function |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2245812A (en) * | 1990-07-12 | 1992-01-15 | Shaklee Corp | Natural antioxidant compositions |
US6432453B1 (en) * | 2000-08-26 | 2002-08-13 | Metagenics, Inc. | Dietary supplement containing glycerol ester of conjugated linoleic acid and rosemary extract containing carnosic acid |
US20040023894A1 (en) * | 2000-10-24 | 2004-02-05 | Nathalie Hasler-Nguyen | Synergistic antioxidant combination of delta tocols and polyphenols |
EP1415549A1 (en) * | 2002-11-01 | 2004-05-06 | Galileo Laboratories, Inc. | Synergistic antioxidant combination of tocols and polyphenols |
US20050244518A1 (en) * | 2000-06-12 | 2005-11-03 | Ruo Huang | Dietary supplement and related method |
-
2006
- 2006-04-14 FR FR0603423A patent/FR2899768B1/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2245812A (en) * | 1990-07-12 | 1992-01-15 | Shaklee Corp | Natural antioxidant compositions |
US20050244518A1 (en) * | 2000-06-12 | 2005-11-03 | Ruo Huang | Dietary supplement and related method |
US6432453B1 (en) * | 2000-08-26 | 2002-08-13 | Metagenics, Inc. | Dietary supplement containing glycerol ester of conjugated linoleic acid and rosemary extract containing carnosic acid |
US20040023894A1 (en) * | 2000-10-24 | 2004-02-05 | Nathalie Hasler-Nguyen | Synergistic antioxidant combination of delta tocols and polyphenols |
EP1415549A1 (en) * | 2002-11-01 | 2004-05-06 | Galileo Laboratories, Inc. | Synergistic antioxidant combination of tocols and polyphenols |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009052924A1 (en) * | 2007-10-22 | 2009-04-30 | Dsm Ip Assets B.V. | Process for producing carnosol from carnosic acid |
US8420835B2 (en) | 2007-10-22 | 2013-04-16 | Dsm Ip Assets B.V. | Process for producing carnosol from carnosic acid |
EP2062899A1 (en) * | 2007-11-21 | 2009-05-27 | DSMIP Assets B.V. | Process for producing carnosol from carnosic acid |
WO2009127073A1 (en) * | 2008-04-18 | 2009-10-22 | Gen Sod2 Foundation | Cosmetic preparation tailored to an individual and method for the production thereof |
EP2753311A1 (en) * | 2011-09-09 | 2014-07-16 | Kemin Industries, Inc. | Antioxidant formulations |
EP2753311A4 (en) * | 2011-09-09 | 2015-04-08 | Kemin Ind Inc | Antioxidant formulations |
WO2014083161A1 (en) * | 2012-11-29 | 2014-06-05 | Nestec S.A. | Increasing the bioavailability of flavan-3-ols with carbohydrates with a low glycemic index |
WO2014083172A1 (en) * | 2012-11-29 | 2014-06-05 | Nestec S.A. | Increasing the bioavailability of flavan-3-ols by polyphenols |
US10709159B2 (en) | 2012-11-29 | 2020-07-14 | Societe Des Produits Nestle S.A. | Increasing the bioavailability of flavan-3-ols with carbohydrates with a low glycemic index |
US10722584B2 (en) | 2012-11-29 | 2020-07-28 | Societe Des Produits Nestle S.A. | Increasing the bioavailability of flavan-3-ols by polyphenols |
WO2021245362A1 (en) * | 2020-06-05 | 2021-12-09 | Adisseo France S.A.S. | Vitamin a formulation |
FR3111051A1 (en) * | 2020-06-05 | 2021-12-10 | Adisseo France S.A.S. | VITAMIN A FORMULATION |
WO2022018281A3 (en) * | 2020-07-24 | 2022-03-10 | Activ'inside | Composition comprising a mixture of extracts of vitis vinifera and vaccinium angustifolium and probiotics to improve cognitive function |
Also Published As
Publication number | Publication date |
---|---|
FR2899768B1 (en) | 2008-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Šamec et al. | Cruciferous (brassicaceae) vegetables | |
Dhyani et al. | A review on nutritional value, functional properties and pharmacological application of perilla (Perilla frutescens L.) | |
Zia et al. | An update on functional, nutraceutical and industrial applications of watermelon by-products: A comprehensive review | |
Marques et al. | Paullinia cupana: a multipurpose plant–a review | |
Bastidas et al. | Quinoa (Chenopodium quinoa Willd), from nutritional value to potential health benefits: an integrative review | |
US10016450B2 (en) | Anti-glycation methods and compositions | |
Martirosyan et al. | Amaranth oil application for coronary heart disease and hypertension | |
Berry et al. | The Middle Eastern and biblical origins of the Mediterranean diet | |
Pons et al. | Effect of low molecular grape seed proanthocyanidins on blood pressure and lipid homeostasis in cafeteria diet-fed rats | |
FR2899768A1 (en) | Food supplement, useful as antioxidant, to improve the organ response or prevent the oxidative stress and to reduce aging, comprises gamma-tocopherol, flavonoids, carnosic acid and carnosol | |
Manosso et al. | Nutritional strategies for dealing with depression | |
EP2629744A1 (en) | Product for treating cellulite, skin ageing and for preventing inflammatory processes | |
EP3368055A1 (en) | Specific nutritional or therapeutic agent including a mixture of grape and blueberry | |
Chen et al. | Functional foods and intestinal homeostasis: The perspective of in vivo evidence | |
FR3080989A1 (en) | LIQUID COMPOSITION COMPRISING AN EXTRACT OF CASSIS LEAVES AND CONCENTRATED APPLE JUICE | |
US9452190B2 (en) | Neuroprotective natural extract from passion fruit | |
FR2962648A1 (en) | COSMETIC OR DERMATOLOGICAL COMPOSITION AND USE THEREOF FOR THE SKIN CARE OF YOUNG MEN | |
JP2013510140A (en) | Fatty liver improving agent composition | |
Satish et al. | Therapeutic Potential Of Benincasa Hispida For The Treatment Of Alzheimer Disease. | |
Sultana et al. | The Beneficial Health Effects of Nuts in the Diet | |
Brewer-Smyth | Brain Food: The Impact of Diet, Nutrition, and Nutraceuticals on the Brain and the Microbiota-Gut-Brain Axis | |
Shehzad et al. | Functional Foods: Concepts and Their Health Perspectives | |
Onyenibe et al. | Use of plant foods from West Africa in the management of metabolic syndrome | |
Saini | Functional Foods for Replacing Chemical Filled Medicines | |
Panse | Nutritional Psychiatry as Basis of Nutraceutical Development for Mental Illness in Aging Population |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 10 |
|
ST | Notification of lapse |
Effective date: 20161230 |